1. Predicting long-term outcome after surgical biliary diversion in Bsep-deficiency patients: Results from the NAPPED consortium

   van Wessel, D., Thompson, R., Grammatikopoulos, T., Kadaristiana, A., Jankowska, I., Lipineski, P., Czubkowski, P., Gonzales, E., Jacquemin, E., Spraul, A., Sokal, E., Shagrani, M. A., Broering, D. C., Algoufi, T., Mazhar, N., Nicastro, E., Kelly, D., Nebbia, G., Arnell, H., Fischler, B., Hulscher, J. B. F., Serranti, D., Arikan, C., Polat, E., Debray, D., Lacaille, F., Goncalves, C., Hierro, L., Munoz Bartolo, G., Mozer-Glassberg, Y., Azaz, A., Brecelj, J., Dezsofi, A., Calvo, P. L., Grabhorn, E., Sturm, E., van der Woerd, W., Kamath, B. M., Wang, J-S., Li Liting, Durmaz, O., Hansen, B. & Verkade, H., Apr-2019, In : Journal of Hepatology. 70, p. E121 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

2. Availability of information in drug labels for appropriate prescribing in patients with hepatic impairment

   Weersink, R. A., Timmermans, L., Monster-Simons, M. H., Mol, P. G. M., Metselaar, H. J., Borgsteede, S. D. & Taxis, K., Apr-2019, In : Journal of Hepatology. 70, p. E347-E348 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Adverse drug reactions in patients with cirrhosis: Analysis of spontaneous reports from the Dutch Pharmacovigilance Centre Lareb

   Weersink, R. A., Taxis, K., van Puijenbroek, E. G. & Borgsteede, S. D., Apr-2019, In : Journal of Hepatology. 70, 1 Supplement, p. E691-E691 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. Monoacylglycerol lipase inhibition protects from hepatic inflammation and fibrosis in mouse models of sclerosing cholangitis

   Tardelli, M., Bruschi, F., Claudel, T., Fuchs, C., Auer, N., Kunczer, V., Stojakovic, T., Ronda, O., Verkade, H., Lotersztajn, S. & Trauner, M., Apr-2019, In : Journal of Hepatology. 70, p. E170-E170 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. A humanized bile acid pool induced by somatic CRISPR/Cas9-mediated deletion of Cyp2c70 modulates effects of pharmacological FXR activation in mice

   de Boer, J. F., Verkade, E., Mulder, N. L., de Vries, H. D., Huijkman, N., Koehorst, M., Boer, T., Wolters, J. C., Bloks, V. W., van de Sluis, B. & Kuipers, F., Apr-2019, In : Journal of Hepatology. 70, p. E25-E26 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (172) »